Chikungunya Cases Rise in the UK Amid Vaccine Safety Concerns
The number of chikungunya cases in the UK has surged by 170%, with 73 reported cases in 2025 compared to […]
Why Patients Aren’t Filling Their Prescriptions—and What’s Being Done
As a pharmacist, I see firsthand how patients often struggle to fill their prescriptions. Despite heavy advertising from drug companies,
New Treatments for Hidradenitis Suppurativa (HS) in Major Markets
Hidradenitis suppurativa (HS) is a chronic skin condition that causes painful lumps and abscesses, often in areas like the armpits
New FDA Leader Aims to Modernize Drug Reviews Amid Challenges
The U.S. Food and Drug Administration (FDA) has appointed Dr. George Tidmarsh as the new director of its Center for
How AI Can Help Doctors and Drug Companies Understand Patient Care Better
Artificial intelligence (AI) is changing how healthcare and drug companies use real-world patient data. But simply using AI isn’t enough—it
News
Bristol Myers Squibb Appoints New Leader for Drug Development
Bristol Myers Squibb has named Dr. Cristian Massacesi as its new Executive Vice President and Chief Medical Officer, overseeing all
New Treatments Could Transform Care for Hidradenitis Suppurativa (HS)
A new report predicts that the market for hidradenitis suppurativa (HS) treatments will grow significantly over the next decade, from
European Regulators Reject Duchenne Muscular Dystrophy Treatment Elevidys
European drug regulators have recommended rejecting Elevidys, a gene therapy for Duchenne muscular dystrophy (DMD), in a setback for its
Uncategorized
Jazz Pharmaceuticals is actively exploring mergers and acquisitions of different sizes as it concludes its legal battles over the patent for Epidiolex, a medication used to treat seizures.
During Jazz Pharmaceuticals’ fourth-quarter earnings call, CEO Bruce Cozadd quickly highlighted the company’s interest in making new deals. Some of the drugs they are known for include Xyrem, used for treating narcolepsy, and Vyxeos, a treatment for certain types of leukemia.
Uncategorized
Understanding Epilepsy: Seeing the Person Behind the Condition Epilepsy is more than just a medical condition; it’s important to see and understand the person who is living with it. While medications like Keppra, Lamictal, and Depakote can help manage seizures, it’s crucial to support the individual as a whole. This means recognizing their experiences, challenges, and strengths, and providing compassionate care that goes beyond just treating the symptoms. Embracing the humanity behind epilepsy care involves listening, empathy, and a commitment to improving the quality of life for those affected.
The text is written by Brad Chapman, who is the Head of U.S. Epilepsy and Rare Syndromes at UCB. It discusses epilepsy and mentions some medications used for treatment, such as Keppra, Briviact, and Vimpat. The aim is to improve understanding of epilepsy and how these medications can help manage the condition.